Skip to main content

CORRECTION article

Front. Neurol., 14 October 2022
Sec. Stroke
Volume 13 - 2022 | https://doi.org/10.3389/fneur.2022.1053112

Corrigendum: Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke

This article is a correction to:

  1. A Combined Clinical and Serum Biomarker-Based Approach May Allow Early Differentiation Between Patients With Minor Stroke and Transient Ischemic Attack as Well as Mid-term Prognostication

    1. Read original article
\nTingting Liu,Tingting Liu1,2Yanan LiYanan Li2Xiaoyuan Niu Xiaoyuan Niu1*Yongle WangYongle Wang2Kaili ZhangKaili Zhang3Haimei FanHaimei Fan4Jing RenJing Ren2Juan LiJuan Li2Yalan FangYalan Fang1Xinyi LiXinyi Li3Xuemei WuXuemei Wu4
  • 1Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, China
  • 2Shanxi Medical University, Taiyuan, China
  • 3The Bethune Hospital of Shanxi Province, Taiyuan, China
  • 4General Hospital of Tisco (Sixth Hospital of Shanxi Medical University), Shanxi, China

A corrigendum on
Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke

by Liu, T., Li, Y., Niu, X., Wang, Y., Zhang, K., Fan, H., Ren, J., Li, J., Fang, Y., Li, X., and Wu, X. (2022). Front. Neurol. 13:937417. doi: 10.3389/fneur.2022.937417

In the published article, there was an error in affiliations 1 and 2. Instead of “1 Shanxi Medical University, Taiyuan, China,” it should be “2 Shanxi Medical University, Taiyuan, China.” Instead of “2 Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, China,” it should be “1 Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, China.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: factors, physician, decision-making, antiplatelet therapy, minor stroke

Citation: Liu T, Li Y, Niu X, Wang Y, Zhang K, Fan H, Ren J, Li J, Fang Y, Li X and Wu X (2022) Corrigendum: Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke. Front. Neurol. 13:1053112. doi: 10.3389/fneur.2022.1053112

Received: 25 September 2022; Accepted: 26 September 2022;
Published: 14 October 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Liu, Li, Niu, Wang, Zhang, Fan, Ren, Li, Fang, Li and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xiaoyuan Niu, niuxiaoyuan1958@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.